Brain Tumor
Showing 26 - 50 of 279
Brain Tumor Trial in Rochester (InSightec's ExAblate Neuro Model 4000 Type 2.0 (220 KHz) system)
Recruiting
- Brain Tumor
- InSightec's ExAblate Neuro Model 4000 Type 2.0 (220 KHz) system
-
Rochester, MinnesotaMayo Clinic Minnesota
Feb 8, 2023
Cognition, Brain Tumor, Magnetic Resonance Imaging Trial in Gent, Leuven, Wilrijk (behavioral, diagnostic test, other)
Not yet recruiting
- Cognition
- +5 more
- Neurocognitive tests: WAIS digit span, HVLT-R, COWAT, MOCA, WAIS digit symbol substitution, TMT A&B, Stroop Color Word Test
- +3 more
-
Gent, Belgium
- +2 more
Feb 3, 2023
Brain Tumor, Cancer Trial run by the National Cancer Institute (NCI) (Zotiraciclib)
Not yet recruiting
- Brain Tumor
- Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Spiritual Needs on Spiritual Well-Being in Brain Tumors: A
Withdrawn
- Brain Tumor
- Patient population
-
Houston, TexasM D Anderson Cancer Center
Jan 31, 2023
Space Occupying Lesions of the Brain
Recruiting
- Brain Tumor
- +2 more
- MR-scans using a 3T Prisma and a 7T Terra scanner (Siemens, Erlangen Germany)
-
Bern, SwitzerlandInstitute for Diagnostic and Interventional Neuroradiology, Univ
Jan 26, 2023
Lactate in Patients Undergoing Glial and Non Glial Mass Surgery
Completed
- Lactate
- +2 more
- lactate level
- Glasgow Outcome Scale
-
Edirne, Centrum, TurkeyTrakya University
Jan 17, 2023
Score After Elective Intracranial Neurosurgery Operation
Recruiting
- Brain Tumor
- +2 more
- Quality of Recovery-15
- +2 more
-
Edirne, Centrum, TurkeyTrakya University
Jan 17, 2023
Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and
Recruiting
- Malignant Glioma of Brain
- +8 more
- Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
-
Detroit, MichiganHenry Ford Health System
Jan 9, 2023
Brain Tumor Trial in Toronto (Exablate, Doxorubicin)
Recruiting
- Brain Tumor
- Exablate
- Doxorubicin
-
Toronto, Ontario, CanadaSunnybrook Research Institute
Jan 5, 2023
Brain Tumor Trial in Washington (Exablate, Doxorubicin)
Recruiting
- Brain Tumor
- Exablate
- Doxorubicin
-
Washington, District of ColumbiaChildren's National Medical Center
Jan 4, 2023
Biological Collection of Brain Tumors
Not yet recruiting
- Brain Tumor
- blood and/or csf collection
-
Bron, Rhône, FranceHospices Civils de Lyon
Dec 28, 2022
Brain Tumor, Head Neck Cancer Trial in Washington, Baltimore (radiation, other, diagnostic test)
Not yet recruiting
- Brain Tumor
- Head and Neck Cancer
- substructure informed planning
- +2 more
-
Washington, District of Columbia
- +1 more
Dec 13, 2022
Brain Tumor Trial (Propofol, Sevoflurane)
Recruiting
- Brain Tumor
-
Kaohsiung, TaiwanKaohsiung Medical University Chung-Ho Memorial Hospital
Dec 15, 2022
Glioblastoma, Brain Tumor, Cannabis Trial in United Kingdom (Sativex, Temozolomide, Sativex-matched )
Not yet recruiting
- Glioblastoma
- +3 more
- Sativex
- +2 more
-
Belfast, United Kingdom
- +14 more
Nov 29, 2022
OPTIMIZATION of ADVANCED MR SEQUENCES
Recruiting
- Neurosciences
- +4 more
-
Paris, FranceOPPENHEIM Catherine
Nov 17, 2022
A Comprehensive Clinical fMRI Software Solution to Enable
Recruiting
- Brain Tumor
-
Houston, TexasM D Anderson Cancer Center
Nov 11, 2022
Brain Metastases, Glioma of Brain, Brain Tumor Trial in Los Angeles (Dynamic Contrast-Enhanced Magnetic Resonance Imaging,
Recruiting
- Brain Metastases
- +3 more
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- Bevacizumab Injection
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 12, 2022
Brain Tumor Trial in Stanford (Panitumumab-IRDye800, Pinpoint-IR9000 endoscopic/handheld device, Explorer Air camera)
Not yet recruiting
- Brain Tumor
- Panitumumab-IRDye800
- +3 more
-
Stanford, CaliforniaStanford Cancer Center
Nov 9, 2022
Brain Tumor Trial (Blood Brain Barrier Disruption - Oncology, Pembrolizumab)
Recruiting
- Brain Tumor
- Blood Brain Barrier Disruption - Oncology
- Pembrolizumab
-
Phoenix, Arizona
- +3 more
Nov 4, 2022
Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)
Active, not recruiting
- Brain Tumor
- +12 more
- Prexasertib
- +4 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 20, 2022
Monitoring Neural Tissues Properties by Modulated Imaging (MI)
Withdrawn
- Brain Tumor
- Modulated Imaging
-
Irvine, California
- +1 more
Oct 19, 2022
Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)
Recruiting
- Adenocarcinoma
- +75 more
- Biomarker Testing (L)
- +2 more
-
Idaho Falls, Idaho
- +1 more
Oct 18, 2022
Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma Trial in New York (Intra-arterial Cetuximab, Intra-arterial
Recruiting
- Glioblastoma
- +8 more
- Intra-arterial Cetuximab
- +2 more
-
New York, New YorkLenox Hill Brain Tumor Center
Oct 17, 2022
Medical Marijuana in Pediatric Central Nervous System Tumor
Active, not recruiting
- Central Nervous System Tumor
- +2 more
-
Aurora, ColoradoChilsdren's Hospital Colorado
Oct 14, 2022
Glioblastoma, Brain Tumor, Glioma Trial in United States (Procedure: LITT, Hypo-Fractionated Radiation Therapy)
Recruiting
- Glioblastoma
- +3 more
- Procedure: LITT
- Hypo-Fractionated Radiation Therapy
-
Baltimore, Maryland
- +3 more
Oct 10, 2022